Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 788 across all filing types
Latest filing 2024-04-08 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于全资子公司产品获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding a subsidiary obtaining a medical device registration certificate. It includes details about the certificate, its approval date, and the expected impact on the company. There is no financial data, no mention of financial results, no regulatory filings about financial performance, no voting results, no management changes, or other report types. The document is an official announcement about a regulatory approval related to the company's product line. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a non-financial matter. Therefore, the best fitting category is Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2024-04-08 Chinese
关于2024年第一季度可转换公司债券转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the convertible bonds (可转换公司债券) conversion situation for the first quarter of 2024. It details the number of bonds converted into shares, the remaining convertible bonds, changes in share capital, and relevant regulatory approvals and board decisions. The document includes specific bond codes, stock codes, dates, and references to regulatory rules and disclosures. The length is 3274 characters, which is relatively short and focused on a specific capital market event rather than a full financial report. It is not a full annual or interim report, nor an earnings release or management discussion. It is a formal announcement about convertible bond conversions and resulting share capital changes, which fits the category of Capital/Financing Update (CAP).
2024-04-01 Chinese
第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the seventh meeting of the fourth board of directors of 康泰医学系统（秦皇岛）股份有限公司. It details the meeting date, attendance, and the approval of a proposal regarding the use of idle funds for cash management. There is no financial report, audit, or detailed financial data presented. The document is a formal disclosure of board decisions, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is MANG with high confidence.
2024-03-04 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司继续使用闲置自有资金进行现金管理的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed opinion and verification report from a sponsoring securities company regarding the continued use of idle self-owned funds by a listed company for cash management purposes. It includes descriptions of the board resolutions, investment scope, risk control measures, and the sponsor's conclusion that the use of funds is compliant and beneficial. The document is not a financial report like an annual or interim report, nor is it a brief announcement or voting result. It is a formal verification or audit opinion related to a specific financial activity, which fits the category of an Audit Report / Information (AR). The document length is about 2,539 characters, which is sufficient for a substantive report rather than a mere announcement. Therefore, the classification is AR with high confidence. FY 2024
2024-03-04 Chinese
关于继续使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from 康泰医学系统（秦皇岛）股份有限公司 regarding the continuation of using idle own funds for cash management. It details the board resolutions, investment purpose, risk control measures, and the approval process. The document is a formal disclosure about financing activities related to cash management and investment of idle funds, including authorization and risk assessment. It does not contain financial statements or detailed financial results, nor is it a report or transcript. It is an update on the company's capital management activities, specifically the use of idle funds for cash management. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 2385 characters, which is consistent with an announcement rather than a full report.
2024-03-04 Chinese
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (618 characters) regarding the company obtaining a medical device registration certificate issued by a regulatory authority. It includes details about the certificate, product, and impact on the company. There is no financial data, no mention of financial results, no detailed report content, and no indication of a meeting or voting results. The document is an official announcement about a regulatory approval, which does not fit into financial report categories like Annual Report, Interim Report, or Earnings Release. It is not a certification or officer attestation. Given the nature and length, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2024-02-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.